Test Price
2,800 AED✅ Home Collection Available
FCGR2B Gene Malaria Resistance Test – UAE
Executive Summary & Core Metrics
The FCGR2B Gene Malaria Resistance Test provides a genetic assessment of innate susceptibility to severe malaria using next-generation sequencing (NGS). This advanced screening is compliant with UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-certified processing.
- Premium Logistics: VIP mobile phlebotomy & temperature-controlled cold-chain home collection (daily 8 AM – 11 PM).
- Clinical Guidance: Post-test telephonic consultation for result interpretation.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The FCGR2B Gene Malaria Resistance Test is a next-generation sequencing (NGS) genetic analysis that identifies variants in the FCGR2B gene associated with innate resistance to malaria. This advanced genomic screening offers crucial insights for individuals of all ages, particularly those with a family history of Plasmodium infections, facilitating personalized preventive strategies and clinical decision-making.
Comparative Test Metrics
| Parameter | Our Test (NGS) | Closest Alternative (PCR-based) |
|---|---|---|
| Precision | Full gene sequencing with 99.99% analytical sensitivity | Targeted mutation panels with ~95% sensitivity |
| Methodology | NGS (Next Generation Sequencing) | PCR amplification & Sanger sequencing |
| Turnaround Time | 3–4 weeks | 1–2 weeks (limited panel) |
| Comprehensiveness | All single nucleotide variants (SNVs) and structural rearrangements | Only known hot-spot mutations |
Physician Insight & Safety Protocols
“As a DHA-licensed Consultant Medical Geneticist, I confirm that the FCGR2B gene assessment is a safe, non-invasive DNA screening that provides key insights into innate malaria susceptibility. A positive result indicates a potential genetic advantage but does not replace clinical preventive measures. All data is handled under UAE PDPL and Federal Law No. 2 of 2019.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA ID: 9294403)
Medication Advisory: Do not discontinue prescribed medications without consulting your physician.
Advisory Precautions
Important Considerations
Genetic testing for malaria resistance yields predictive information. A negative result does not rule out infection risk. Always correlate results with clinical history and family background. Consultation with a genetic counsellor is recommended for comprehensive interpretation.
Exclusion Criteria & Emergency Signals
- Exclusions: Pregnancy (risk of genetic counselling complexity), severe anemia requiring immediate transfusion, active high fever.
- Red Flags: Unexpected severe adverse reactions post-phlebotomy, signs of infection at collection site, sudden collapse – seek emergency care.
- Age restriction: Not recommended for individuals under 18 years without parental consent per Federal Decree-Law No. 4 of 2016 on Medical Liability.
Patient FAQ & Clinical Guidance
1. What is the FCGR2B gene and how does it relate to malaria resistance?
Snippet: The FCGR2B gene encodes a receptor that modulates immune response, and specific variants can significantly reduce susceptibility to severe malaria. This test examines your DNA for these protective mutations, allowing a personalized risk assessment.
2. How is the sample collected and is home collection available?
Snippet: A simple blood draw or a single drop of blood on an FTA card is collected by a certified phlebotomist during our hospital-grade home visit service. We utilise ISO-certified cold-chain logistics to guarantee sample integrity from your doorstep to the lab. VIP Mobile Phlebotomy is available daily from 8 AM to 11 PM.
3. What is the turnaround time and how will I receive my results?
Snippet: Results are typically delivered within 3 to 4 weeks via a secure online portal, and a telephonic consultation with our genetic counsellor is included to interpret your personal genetic risk profile. All data is protected under UAE PDPL.
UAE Regulatory & Data Privacy Adherence
Compliance Framework
This test adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE operates under DHA Facility License No. 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.
Clinical & Logistical Metadata
| Test Name | FCGR2B Gene Malaria Resistance Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral blood (venous or FTA card) |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | Z13.89 |
| LOINC Code | 88825-8 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians